Ultimately, drugs aimed at Cdkn1c may provide a way to increase BAT thermogenesis in adult humans to increase whole-body energy expenditure and address the global epidemic of obesity. The gene discussed is CDKN1C; the disease is obesity due to melanocortin 4 receptor deficiency.